Us Bancorp \De\ Precigen, Inc. Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$1.91 - $3.98 $695 - $1,448	-364 Reduced 42.23%	498 $1,000
Q2 2021 Aug 05, 2021	SELL	$6.24 - $8.22 $1,248 - $1,644	-200 Reduced 18.83%	862 $6,000
Q1 2021 Apr 28, 2021	BUY	$6.74 - $10.95 $1,348 - $2,190	200 Added 23.2%	1,062 $7,000
Q3 2020 Nov 10, 2020	SELL	$3.5 - $6.2 $3,500 - $6,200	-1,000 Reduced 53.71%	862 $3,000
Q2 2020 Aug 07, 2020	BUY	$2.16 - $5.46 $786 - $1,987	364 Added 24.3%	1,862 $9,000
Q1 2020 May 13, 2020	BUY	$1.46 - $7.19 $2,187 - $10,770	1,498 New	1,498 $5,000

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $348M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.